Literature DB >> 1279205

Mutational analysis of the fingers domain of human immunodeficiency virus type 1 reverse transcriptase.

P L Boyer1, A L Ferris, S H Hughes.   

Abstract

Using BspMI cassette vectors, we have constructed a series of mutations in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) that cause specific amino acid substitutions within the polymerase domain. The RNA-dependent DNA polymerase, DNA-dependent DNA polymerase, and RNase H activities of the mutant RTs were assayed. The elucidation of the structure of HIV-1 RT makes it possible to determine the locations of specific mutations in the three-dimensional structure of HIV-1 RT [E. Arnold, A. Jacobo-Molina, R. G. Nanni, R. L. Williams, X. Lu, J. Ding, A. D. Clark, Jr., A. Zhang, A. L. Ferris, P. Clark, A. Hizi, and S. H. Hughes, Nature (London) 357:85-89, 1992; L. A. Kohlstaedt, J. Wang, J. M. Friedman, P. A. Rice, and T. A. Steitz, Science 256:1783-1790, 1992]. The mutations described in this report are between amino acids 25 and 81, within the "fingers" domain of RT (Kohlstaedt et al., Science 256:1783-1790, 1992). It has been suggested that this domain may play a role in positioning the template. Although the fingers domain does not contain the active site for polymerization, several of the mutations within this domain disrupt polymerase activity without significantly affecting RNase H activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1279205      PMCID: PMC240464          DOI: 10.1128/JVI.66.12.7533-7537.1992

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV.

Authors:  F di Marzo Veronese; T D Copeland; A L DeVico; R Rahman; S Oroszlan; R C Gallo; M G Sarngadharan
Journal:  Science       Date:  1986-03-14       Impact factor: 47.728

2.  In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine.

Authors:  Q Gao; Z X Gu; M A Parniak; X G Li; M A Wainberg
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

3.  Isolation and characterization of a dideoxyguanosine triphosphate-resistant mutant of human immunodeficiency virus reverse transcriptase.

Authors:  V R Prasad; I Lowy; T de los Santos; L Chiang; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

4.  Chimeric human immunodeficiency virus type 1/type 2 reverse transcriptases display reversed sensitivity to nonnucleoside analog inhibitors.

Authors:  C K Shih; J M Rose; G L Hansen; J C Wu; A Bacolla; J A Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

5.  Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors.

Authors:  J H Nunberg; W A Schleif; E J Boots; J A O'Brien; J C Quintero; J M Hoffman; E A Emini; M E Goldman
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

6.  Zidovudine-resistant human immunodeficiency virus selected by passage in cell culture.

Authors:  B A Larder; K E Coates; S D Kemp
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

7.  Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase.

Authors:  M H St Clair; J L Martin; G Tudor-Williams; M C Bach; C L Vavro; D M King; P Kellam; S D Kemp; B A Larder
Journal:  Science       Date:  1991-09-27       Impact factor: 47.728

8.  Site-specific mutagenesis of AIDS virus reverse transcriptase.

Authors:  B A Larder; D J Purifoy; K L Powell; G Darby
Journal:  Nature       Date:  1987 Jun 25-Jul 1       Impact factor: 49.962

9.  Subunit-selective mutagenesis indicates minimal polymerase activity in heterodimer-associated p51 HIV-1 reverse transcriptase.

Authors:  S F Le Grice; T Naas; B Wohlgensinger; O Schatz
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

10.  AIDS virus reverse transcriptase defined by high level expression in Escherichia coli.

Authors:  B Larder; D Purifoy; K Powell; G Darby
Journal:  EMBO J       Date:  1987-10       Impact factor: 11.598

View more
  25 in total

1.  Analysis of mutations at positions 115 and 116 in the dNTP binding site of HIV-1 reverse transcriptase.

Authors:  P L Boyer; S G Sarafianos; E Arnold; S H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

2.  Phenotypic characterization of three phylogenetically conserved stem-loop motifs in the mengovirus 3' untranslated region.

Authors:  H Duque; A C Palmenberg
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase.

Authors:  J G Julias; A L Ferris; P L Boyer; S H Hughes
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Mutations in the RNase H domain of HIV-1 reverse transcriptase affect the initiation of DNA synthesis and the specificity of RNase H cleavage in vivo.

Authors:  John G Julias; Mary Jane McWilliams; Stefan G Sarafianos; Edward Arnold; Stephen H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

5.  Steered molecular dynamics simulation on the binding of NNRTI to HIV-1 RT.

Authors:  Lingling Shen; Jianhua Shen; Xiaomin Luo; Feng Cheng; Yechun Xu; Kaixian Chen; Edward Arnold; Jianping Ding; Hualiang Jiang
Journal:  Biophys J       Date:  2003-06       Impact factor: 4.033

6.  Effects on DNA synthesis and translocation caused by mutations in the RNase H domain of Moloney murine leukemia virus reverse transcriptase.

Authors:  S W Blain; S P Goff
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

7.  Reversion of a Moloney murine leukemia virus RNase H mutant at a second site restores enzyme function and infectivity.

Authors:  S W Blain; W A Hendrickson; S P Goff
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

8.  Replication defect of moloney murine leukemia virus with a mutant reverse transcriptase that can incorporate ribonucleotides and deoxyribonucleotides.

Authors:  G Gao; S P Goff
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Analysis of nonnucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  P L Boyer; M J Currens; J B McMahon; M R Boyd; S H Hughes
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

10.  Mutational analysis of the reverse transcriptase and ribonuclease H domains of the human foamy virus.

Authors:  D Kögel; M Aboud; R M Flügel
Journal:  Nucleic Acids Res       Date:  1995-07-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.